AIM
AIM ImmunoTech Inc. (AIM)
NYSE · Healthcare
AIM ImmunoTech Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- AIM ImmunoTech Inc. revenue for the quarter ending March 31, 2026 was 22000, a 37.50% increase year-over-year.
- AIM ImmunoTech Inc. revenue for the twelve months ending March 31, 2026 was 89000, a 47.95% decrease year-over-year.
- AIM ImmunoTech Inc. annual revenue for 2025 was 88000, a 48.24% decrease from 2024.
- AIM ImmunoTech Inc. annual revenue for 2024 was 170000, a 15.84% decrease from 2023.
- AIM ImmunoTech Inc. annual revenue for 2023 was 202000, a 43.26% increase from 2022.
- AIM ImmunoTech Inc. annual revenue for 2022 was 141000.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
AIM ImmunoTech Inc. Earnings — FAQ
AIM ImmunoTech Inc. (AIM) earnings over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIM's earnings history?
The chart and table above show AIM ImmunoTech Inc.'s earnings by year and by quarter, including the growth rate.